Armelle D.
- Country
- France
- Department
- Département d’oncologie médicale
Research Overview
- Phase 1b/2 Evaluation of Efficacy and Safety of GSK5764227 in Adults with Relapsed/Refractory Unresectable Advanced Osteosarcoma or Metastatic Soft‑Tissue Sarcoma
- Evaluation of Perioperative Doxorubicin, Ifosfamide, and Dacarbazine in CINSARC High-Risk Localized Soft Tissue Sarcoma Patients
- Evaluation of Ezabenlimab and BI 907828 in Adult Patients with Locally Advanced or Metastatic Solid Tumors: A Phase II Clinical Trial
Data & Insights
Has run more than one trial at 21 of 29 partner sites.
Specializations
Advanced Sarcoma Management
The investigator specializes in treating various forms of advanced and metastatic sarcomas, with particular emphasis on soft tissue sarcomas and rare sarcoma subtypes.
- Undifferentiated pleomorphic sarcoma
- Osteosarcoma
- Ewing sarcoma
- Leiomyosarcoma
Focused on developing treatment strategies for elderly patients with metastatic sarcoma presentations.
Therapeutic Innovations
Explores innovative therapeutic combinations including immunotherapy approaches and targeted treatments for sarcoma management.
- Immunotherapy combinations
- Targeted molecular therapies
- Chemotherapy optimization
- Novel drug combinations
Investigates the effectiveness of various therapeutic combinations in treating advanced sarcomas.
Perioperative Care
Specializes in perioperative treatment strategies for patients with resectable soft tissue sarcomas, particularly focusing on high-risk CINSARC patients.
- Neoadjuvant chemotherapy
- Surgical management
- Risk-adapted treatment
- Metastasis prevention
Develops comprehensive treatment approaches combining surgery with systemic therapies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.